B cell–ablative therapy for the treatment of autoimmune diseases

This publication has 16 references indexed in Scilit:

• Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: Evidence for a pathogenetic role of B cells
  Arthritis & Rheumatism, 2002
• Anti‐CD20 monoclonal antibody (Rituximab) for life‐threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus
  British Journal of Haematology, 2002
• Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
  Blood, 2001
• Successful treatment with rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low‐grade non‐Hodgkin's lymphoma
  American Journal of Hematology, 2001
• Refractory autoimmune thrombocytopenic purpura treatment with Rituximab
  American Journal of Hematology, 2001
• Remission of severe cold agglutinin disease Rituximab therapy
  Leukemia, 2001
• Monotherapy with Rituximab Induces Rapid Remission of Recurrent Cold Agglutinin-Mediated Hemolytic Anemia in a Patient with Indolent Lympho-Plasmacytic Lymphoma
  Leukemia & Lymphoma, 2001
• Rituximab for myasthenia gravis developing after bone marrow transplant
  Neurology, 2000
• Anti-CD20 Chimeric Monoclonal Antibody Treatment of Refractory Immune-Mediated Thrombocytopenia in a Patient with Chronic Graft-versus-Host Disease
  Annals of Internal Medicine, 2000
• Rituxan in the Treatment of Cold Agglutinin Disease
  Blood, 1998